NCT04313140 Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
| NCT ID | NCT04313140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poitiers University Hospital |
| Condition | Development of the Virtual Biopsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-02-22 |
| Primary Completion | 2029-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2021-02-22 with a primary completion date of 2029-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.
Eligibility Criteria
Inclusion Criteria: * Age≥ 18 years, * Patient with suspected glioma with prior imaging * Subject free, with legal protection guardianship or curatorship; * Enrollment in the French Social Security system; * Informed consent signed by the patient Exclusion Criteria: * Any contraindication to an MRI examination * Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations * Pregnant or lactating women, women of childbearing age who do not have effective contraception
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04313140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Development of the Virtual Biopsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04313140 currently recruiting?
Yes, NCT04313140 is actively recruiting participants. Contact the research team at remy.guillevin@chu-poitiers.fr for enrollment information.
Where is the NCT04313140 trial being conducted?
This trial is being conducted at Poitiers, France.
Who is sponsoring the NCT04313140 clinical trial?
NCT04313140 is sponsored by Poitiers University Hospital. The trial plans to enroll 500 participants.